Bajaj HealthCare Intrinsic Value
BAJAJHCARE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹319.00 | ₹255.20 - ₹382.80 | -19.5% | EPS: ₹14.50, Sector P/E: 22x |
| Book Value Method | asset | ₹582.50 | ₹524.25 - ₹640.75 | +47.1% | Book Value/Share: ₹291.25, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹741.25 | ₹667.12 - ₹815.38 | +87.1% | Revenue/Share: ₹370.62, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹605.91 | ₹545.32 - ₹666.50 | +53.0% | EBITDA: ₹98.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹158.44 | ₹126.75 - ₹190.13 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹118.83 | ₹106.95 - ₹130.71 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹213.80 | ₹192.42 - ₹235.18 | -46.0% | Revenue Growth: -3.4%, Adj P/E: 14.7x |
| ROE Based Valuation | profitability | ₹287.50 | ₹258.75 - ₹316.25 | -27.4% | ROE: 9.9%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹308.25 | ₹277.43 - ₹339.08 | -22.2% | EPS: ₹14.50, BVPS: ₹291.25 |
Want to compare with current market value? Check BAJAJHCARE share price latest .
Valuation Comparison Chart
BAJAJHCARE Intrinsic Value Analysis
What is the intrinsic value of BAJAJHCARE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Bajaj HealthCare (BAJAJHCARE) is ₹308.25 (median value). With the current market price of ₹396.10, this represents a -22.2% variance from our estimated fair value.
The valuation range spans from ₹118.83 to ₹741.25, indicating ₹118.83 - ₹741.25.
Is BAJAJHCARE undervalued or overvalued?
Based on our multi-method analysis, Bajaj HealthCare (BAJAJHCARE) appears to be trading above calculated value by approximately 22.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 5.11 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.79 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 9.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Bajaj HealthCare
Additional stock information and data for BAJAJHCARE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹22 Cr | ₹15 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹92 Cr | ₹87 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-22 Cr | ₹-69 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹-37 Cr | Positive Operating Cash Flow | 6/10 |
| March 2021 | ₹44 Cr | ₹-11 Cr | Positive Operating Cash Flow | 6/10 |